![Ajay Major: Critically important multiple myeloma study from ASH23](https://oncodaily.com/pub/uploads/2023/08/Ajay-Major-1-e1722435486378.jpeg)
Photo from Ajay Major/LinkedIn
Dec 17, 2023, 17:14
Ajay Major: Critically important multiple myeloma study from ASH23
Quoting Ajay Major, Assistant Professor at the University of Colorado School of Medicine and Founder and President at Pager Publications, on X/Twitter:
”Impact of dexamethasone dose in 1L MM. Rahul Banerjee, ASH23:
– 541 pts from 2 SWOG trials
– no diff in PFS or OS between full-dose and down dose
– also no diff in PFS/OS for very-low-dose dex (>50% less during induction).
Critically important multiple myeloma study!”
For the article click here.
Source: Ajay Major/X
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023